2017-06-22T17:49:20-05:00 2016-12-31 MKR ACCOUNTING 6927 Saroni Drive Oakland CA 94611 990 2016-01-01 943473864 Sens Research Foundation Inc SENS 6509386100 110 Pioneer Way No J Mountain View CA 94041 Michael Kope President/CEO 6509386100 2017-06-22 1 P01023106 5103380692 X 98.210.218.87 2017-06-22 17:49:17 PD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 544523E70145B1EE4D4DF12539BB2F50E2BAD54E 2016 2021-01-29 14:40:06Z Michael Kope 110 Pioneer Way No J Mountain View CA 94041 2701563 0 X WWW.SENS.ORG X 2009 CA Develop, promote and ensure widespread access to rejuvenation biotechnologies. 11 10 23 12 0 0 1429790 2684540 134800 10559 6817 3908 7081 2556 1578488 2701563 759769 911907 0 0 1694521 1567225 0 0 427487 1691390 1513936 4145680 3993068 -2567192 -1291505 3493668 2343090 104564 271358 3389104 2071732 X SENS Research Foundation works to research, develop and promote comprehensive regenerative medicine solutions for the diseases and disabilities of aging. The research is governed by a strategic agenda to demonstrate the feasibility of rejuvenation biotechnologies, as a natural extension of regenerative medicine as applied to aging, and therefore drive broader involvement. 0 0 834045 The intramural research program is carried out in the Organization's Mountain View facility by employees of the Organization. The program is comprised of three (3) separate lines of research: Cancer, Mitochondrial mutations, and Lysosomal storage. The Lysosomal project is ongoing part-time at the Research Center. The Cancer line of research is screening a wide range of drug candidates, looking for therapeutic candidates for their research after filing their patent. The Mitochondrial mutations line of research has completed proof of concept and is moving ahead with their work, presenting their findings at conferences internationally. 759570 720222 Extramural Research - the extramural research program funds some of the most prestigious institutions around the world. Many of our extramural research projects this year either completed or were discontinued. Three new projects, and two new sub-projects, were begun due to new grants being received. A couple programs completed their studies and have been discontinued. Funding for this program continues to be prioritized for projects that meet our company mission and are currently being unaddressed in our intramural research program. 397787 191685 SRF Education - As part of its mission, the Organization is committed to educating students and the public about rejuvenation biotechnologies. The Organization's student program, SRF Education Academic Initiative, is committed to educating students and the public. SRF Education operates a summer internship program that places students at the SRF Research Center and outside institutions.The program continues to grow in size and outreach capacities. 232644 13115 Educational Conferences - In addition to participation in a variety of scientific and public engagements, the Organization organizes its own conferences and events. These include the now-annual Rejuvenation Biotechnology conference in the Bay area of California, as well as a variety of roundtable symposiums. This outreach is intended to inform both the scientific community and the general public about damage repair strategies for improving healthcare. 697376 Other programs - The Organization conducts other programs related to the mission of the organization. 930020 13115 2921422 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 1 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 25 0 1 23 1 0 0 0 0 0 0 0 0 0 0 X 11 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X The Organization 6509386100 110 Pioneer Way J Mountain View CA 94041 Barbara Logan Chairperson 1.00 X X 0 0 0 Kevin Perrott Treasurer 1.00 X X 0 0 0 Bill Liao Secretary 1.00 X X 0 0 0 Kevin Dewalt Director 1.00 X 0 0 0 James O'Neill Director 1.00 X 0 0 0 Jonathan Cain Director 1.00 X 0 0 0 Blake Masters Director 1.00 X 0 0 0 Frank Schuler Director 1.00 X 0 0 0 Michael Kope President/CEO 50.00 X X 203859 0 12232 Aubrey de Grey Chief Science Officer 50.00 X 50934 0 0 Jerrienne Barrett Development Director 40.00 X 119800 0 0 374593 0 12232 2 0 1 0 110 Pioneer Way LLC 16821 Frank Ave Los Gatos CA 95032 Rent 172638 David Brindley ISIS Flat 45-53 Iffley Road Oxford UK OX41ED Contract Services 134123 Kaiser Permanente 3100 Thornton Ave Burbank CA 91504 Health Insurance 117263 3 2684540 2684540 Conference registratio 611600 10559 10559 10559 3908 3908 Publication sales 900099 2556 2556 2556 2701563 13115 0 3908 X 603872 603872 29310 29310 278725 278725 254794 109551 81544 63699 1064113 785687 165523 112903 146373 90484 39722 16167 101945 69554 19084 13307 18516 13218 4248 1050 61200 61200 417746 190981 74305 152460 10905 2610 75 8220 6984 6635 349 224347 148135 64771 11441 231238 185248 27929 18061 189615 178537 3331 7747 89346 79777 9569 13829 13829 Bad debt expense 76000 57500 18500 Equipment and supplies 75029 75006 23 Small computer equipmen 27006 155 21914 4937 Professional Developmen 17550 15357 2193 54625 7715 29764 17146 3993068 2921422 644159 427487 2392045 1987853 655768 0 168410 116065 501972 353082 215737 148890 61708 90282 3493668 2343090 104564 271358 104564 271358 X 625665 930925 2763439 1140807 3389104 2071732 3493668 2343090 X -1291505 -25867 X X 0 1 X 1 0 X 1875851 1616007 1650337 1429790 2684540 9256525 1875851 1616007 1650337 1429790 2684540 9256525 5461487 3795038 5764 7822 5600 6817 3908 29911 -1192 7081 5889 9292325 511674 0.40840 0.39500 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 422681 279170 143511 79291 73912 5379 148890 X 2701563 0 2701563 0 2701563 4018935 25867 25867 3993068 0 3993068 Part X, Line 2: The Organization evaluates its uncertain tax positions and will recognize a loss contingency when it is probable that a liability has been incurred as of the date of the financial statements and the amount of the loss can be reasonably estimated. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount recognized. As of December 31, 2016, management did not identify any uncertain tax positions. Part XI, Line 2d - Other Adjustments: Unrealized loss on foreign currency exchange Part XII, Line 2d - Other Adjustments: Loss on foreign currency exchange 25,867. 0 0 0 0 0 0 0 0 0 0 Europe Research project cost 250000 1 1 Contract research Research Grant 2 28725 Cash Payment 0 0 0 0 0 0 1 Yale University PO Box 208241 New Haven CT 06520 060646973 254361 Research Grant University of Texas Health Science Cntr PO Box 203382 Houston TX 77216 741761309 180990 Research Grant Buck Institute for Research on Aging 8001 Redwood Blvd Novato CA 94945 943030609 76500 Research Grant Rider Institute Inc 5 Green Needles Road Littleton MA 01460 810704492 44871 Research Grant Rice University 6100 Main St MS 317 Houston TX 77005 771109620 30000 Research Grant Wake Forest Institute for Regenerative Medicine Medical Center Blvd WinstonSalem NC 27157 223849199 12000 Research Grant Sanford-Burnham Medical Research Institute 10901 N Torrey Pines Rd La Jolla CA 92037 510197108 4100 Research Grant The Scripps Research Institute 10550 N Torrey Pines Rd La Jolla CA 92037 330435954 550 Research Grant Massachusetts General Hospital 55 Fruit Street Boston MA 02114 041564655 500 Research Grant Research grants 7 29310 Part I, Line 2: The Organization monitors grants at three month intervals. We require interim research reports every three months, which are submitted with the next payment invoice. At the conclusion of each research contract, we require a comprehensive research report and a financial accounting that details how the grant was spent. X X 0 0 0 0 0 0 0 0 0 Michael Kope President/CEO 203859 0 0 0 0 0 12232 0 0 0 216091 0 0 0 Kevin Perrott Kevin Perrott is the treasurer of the board of directors 60000 Annual research grant through Buck Institute Form 990, Part VI, Section B, line 11b The form 990 is reviewed by the president and the the director of operations and presented to the board prior to filing. Form 990, Part VI, Section B, line 12c A formal conflict of interest policy has been adopted by the organization. The policy is reviewed and reaffirmed annually. Form 990, Part VI, Section B, line 15 The president's salary was determined through the budget process by the board of directors. The board used comparable data for determining salaries of all key employees Form 990, Part VI, Section C, line 18 The forms 1023 and 990 are available at the organization's offices upon request. Form 990, Part VI, Section C, line 19 All governing documents, the conflict of interest policy and the financial statements are available at the organization's offices upon request Form 990, Part IX, line 11g Other: Program service expenses 190,981. Management and general expenses 57,895. Fundraising expenses 152,460. Total expenses 401,336. Payroll Service Fees: Program service expenses 0. Management and general expenses 16,410. Fundraising expenses 0. Total expenses 16,410. Form 990, Part XI, line 9: Unrealized loss on foreign currency exchange -25,867. Form 990, Part XII, Line 2c The Organization's audit committee is charged with the responsibility of overseeing the audit and the work of the independent auditors. This process has not changed from prior years.